Stock 000590 TUS-PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tus-Pharmaceutical Group Co., Ltd.

Equities

000590

CNE000000701

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
6.2 CNY -1.12% Intraday chart for Tus-Pharmaceutical Group Co., Ltd. -6.91% -30.80%
04-25 Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-27 Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Tus Pharmaceutical Group Co Ltd, formerly Tus-Guhan Group Corp Ltd, is principally engaged in the manufacture and sale of pharmaceuticals. The Company provides Chinese medicines, including Chinese healthcare products, medicines for cold treatment and anti hyperlipemia medicines, among others. It also provides western medicine preparations, including clindamycin phosphate for injection, lomefloxacin hydrochloride for injection and levofloxacin lactate for injection, among others. The Company distributes its products in domestic markets.

Number of employees: 1,237

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicine Health Care Production
96.7 %
332 94.8 % 391 96.7 % +17.76%
Western Medicine Production
2.6 %
17 4.8 % 10 2.6 % -38.42%
Other
0.7 %
1 0.4 % 3 0.7 % +120.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
68.4 %
272 77.6 % 277 68.4 % +1.78%
International
31.6 %
79 22.4 % 128 31.6 % +62.63%

Managers

Managers TitleAgeSince
Ting Tang DFI
 Director of Finance/CFO 46 16-12-11
Xue Feng PSD
 President 34 20-05-20
Li Jun Yan IRC
 Investor Relations Contact - -
Ding Xing Cao SEC
 Corporate Secretary 56 05-06-09

Members of the board

Members of the board TitleAgeSince
Wei Hua Xie BRD
 Director/Board Member 53 08-06-10
Qi Sen Jiao CHM
 Chairman 43 20-10-25
Ke Biao Yan CHM
 Chairman 58 17-06-07
Xue Feng PSD
 President 34 20-05-20
Ting Tang DFI
 Director of Finance/CFO 46 16-12-11
Zheng Ming Huang BRD
 Director/Board Member 77 20-12-09
Jing Wei Sun BRD
 Director/Board Member 39 20-12-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 239,471,267 127,883,332 ( 53.40 %) 0 53.40 %

Shareholders

NameEquities%Valuation
Everbright PGIM Fund Management Co. Ltd.
0.6757 %
1,508,400 0.6757 % 1 M ¥
Goldstate Capital Fund Management Co., Ltd.
0.4281 %
955,600 0.4281 % 849 834 ¥
SWS MU Fund Management Co., Ltd.
0.3421 %
763,693 0.3421 % 679 167 ¥
Gfund Management Co., Ltd.
0.3404 %
759,900 0.3404 % 675 794 ¥
Western Leadbank Fund Management Co., Ltd
0.2903 %
648,100 0.2903 % 576 368 ¥
Lion Fund Management Co., Ltd.
0.1759 %
392,700 0.1759 % 349 236 ¥
China Asset Management Co., Ltd.
0.1298 %
289,700 0.1298 % 257 636 ¥
GF Fund Management Co., Ltd.
0.1198 %
267,400 0.1198 % 237 804 ¥
Broad Fund Management Co. Ltd.
0.0556 %
124,100 0.0556 % 110 365 ¥
Citic Securities Co., Ltd. (Invt Port)
0.0195 %
43,600 0.0195 % 38 774 ¥

Company contact information

Tus-Pharmaceutical Group Co., Ltd.

1 Luojinqiao Yanfeng District

421001, Hengyang

+

http://www.tuspharma.cn
address Tus-Pharmaceutical Group Co., Ltd.(000590)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TUS-PHARMACEUTICAL GROUP CO., LTD. Stock Tus-Pharmaceutical Group Co., Ltd.
-30.80% 207M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 734B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 591B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 315B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 276B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 238B
NOVARTIS AG Stock Novartis AG
+9.78% 206B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 204B
AMGEN INC. Stock Amgen Inc.
+6.17% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000590 Stock
  4. Company Tus-Pharmaceutical Group Co., Ltd.